Valérie Ingremeau

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A new anticholinergic aerosol containing 0.5mg ipratropium bromide dissolved in 1mL of solution has been produced with the purpose of decreasing nebulization time for patients compared to the traditional formulation which is twice as voluminal (0.5mg/2mL, Boehringer-Ingelheim, France). The aim of this study was to compare aerosol characteristics (inhaled(More)
  • 1